Inventor

KEVIN WAYNE KUNTZ

Inventor
US

Overview

13→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 13 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes26%
C07BGeneral methods of organic chemistry5%
Y02ATechnologies for adaptation to climate change5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to RIBON THERAPEUTICS INC (7)· patent assignee history
2022–2025Patents assigned to EPIZYME INC (4)· patent assignee history
2022–2025Patents assigned to EISAI R&D MAN CO LTD (2)· patent assignee history
2022–2025Based in US· patent location history
2024–2025Patents assigned to BOEHRINGER INGELHEIM INT (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RIBON THERAPEUTICS INC72022–2025
EPIZYME INC42022–2025
BOEHRINGER INGELHEIM INT32024–2025
EISAI R&D MAN CO LTD22022–2025
Locations
LocationPatentsSpan
US132022–2025